Investing Profile

Jay Parrish

InvestorVC
Venture Partner at ARCH Venture Partners
Photo of Jay Parrish, Venture Partner at ARCH Venture Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Financial Services, Financial Technology, and Business Services Network
218 CONNECTIONS
University of California, Berkeley, Haas School of Business Network
212 CONNECTIONS
University of California, Berkeley Network
74 CONNECTIONS
Emory University Network
47 CONNECTIONS
ARCH Venture Partners Network
20 CONNECTIONS
cb
ARCH Venture Partners Venture Partner
$50K - $150.0M
$25.0M
4
$635.8M
CompanyStageDateRound SizeTotal Raised
Gate Bioscience
Series BNov 2025$65M
Series ANov 2023$60M
$130M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Scott Biller (GV (Google Ventures)), Vineeta Agarwala (Andreessen Horowitz), Clare Ozawa (Versant Ventures)
Pretzel Therapeutics
Series ASep 2022$73M
$73M
Co-investors: Anika Gupta (GV (Google Ventures)), David Schenkein (GV (Google Ventures)), Per Samuelsson (HealthCap), Robert Tansley (Cambridge Innovation Capital), Reetika Bhardwaj (ARCH Venture Partners), Kristina Burow (ARCH Venture Partners), Alaa Halawa (Vir Biotechnology, Inc.)
Interline Therapeutics
Series AMay 2021$60M
$60M
Co-investors: Vikram Bajaj (Foresite Capital)
Chairman Of The Board Stealth Company (Jay Parrish)Present
Postdoctoral Fellow Scripps ResearchPresent
Scientist, Medicinal Chemistry Gilead SciencesPresent
Strategic Advisor Financial Services, Financial Technology, and Business ServicesPresent
Corporate Development Gilead SciencesPresent
Instructor Berkeley Venture CapitalPresent
Instructor University of California, BerkeleyPresent
Member Board Of Directors Guide TherapeuticsPresent
Chairman of the Board Lilac TherapeuticsPresent
Member Board Of Directors Interline TherapeuticsPresent
Board Observer Gate BiosciencePresent
Strategic Advisor HI-Bio: A Biogen CompanyPresent
Strategic Advisor Orbital TherapeuticsPresent
Strategic Advisor Vaccine CompanyPresent
Strategic Advisor and Board Member Magnet BiomedicinePresent
Venture Partner ARCH Venture PartnersPresent
Co-Founder and Chief Business Officer Vir Biotechnology, Inc.Present
Co-Founder and Member Board Of Directors ROME TherapeuticsPresent
Chairman and CEO Pretzel TherapeuticsPresent
Co-Founder and Chairman Amplitude TherapeuticsPresent
Emory University BS Chemistry
University of South Florida PhD Synthetic Organic Chemistry
University of California, Berkeley, Haas School of Business MBA Finance
Sign in with Google →
Sign in with Google →